|
|
Volumn 105 Suppl 2, Issue , 2012, Pages
|
|
Non-tuberculous mycobacteria in cystic fibrosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ETHAMBUTOL;
MACROLIDE;
RIFAMPICIN;
ATYPICAL MYCOBACTERIOSIS;
ATYPICAL MYCOBACTERIUM;
COMORBIDITY;
CYSTIC FIBROSIS;
DRUG COMBINATION;
FEMALE;
HOSPITALIZATION;
HUMAN;
ISOLATION AND PURIFICATION;
LUNG FUNCTION TEST;
MALE;
MICROBIOLOGY;
PATHOPHYSIOLOGY;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
COMORBIDITY;
CYSTIC FIBROSIS;
DRUG THERAPY, COMBINATION;
ETHAMBUTOL;
FEMALE;
HUMANS;
MACROLIDES;
MALE;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
NONTUBERCULOUS MYCOBACTERIA;
PROGNOSIS;
RESPIRATORY FUNCTION TESTS;
RIFAMPIN;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 84865286926
PISSN: None
EISSN: 17581095
Source Type: Journal
DOI: 10.1258/jrsm.2012.12s003 Document Type: Review |
|
Times cited : (21)
|
|
References (0)
|
